Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials.
about
When to start aripiprazole therapy in patients with bipolar maniaThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmGenetics of Common Antipsychotic-Induced Adverse EffectsCost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context.Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyTreatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Exclusion of overlapping symptoms in DSM-5 mixed features specifier: heuristic diagnostic and treatment implications.Treatment recommendations for DSM-5-defined mixed features.Mixed states in bipolar disorder - changes in DSM-5 and current treatment recommendations.Treatment of mixed features in bipolar disorder.Treating mixed mania/hypomania: a review and synthesis of the evidence.Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials.Neurofunctional effects of quetiapine in patients with bipolar mania.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight
P2860
Q27014860-54E107EE-2034-406E-B32B-BD3D1955B29BQ28066714-BC76DDCC-1D19-47C2-B388-3F7697763689Q28072893-27A28912-6867-4B70-91F4-7AB49FEAE6B6Q34100578-C899C5BB-16F1-4339-A3D5-5B3F1CDDB9AAQ34676317-798A8AFB-8862-48FB-9003-851BDD155AD2Q34823805-CA4CF0A9-C2A4-46BD-9872-CEF5E2671609Q35862776-DEDBA28F-CEED-4140-89F1-3188EB7566A7Q38792840-F7E65210-02FD-425C-9072-DE2073BF8638Q38821179-B09234F2-6F2D-4FB9-B35E-F0D17639E1D6Q38833165-9B3CD9EA-68F4-459B-887C-62C3CBDA14B2Q38952103-9C04F4C7-E35F-4F1F-BEB0-9395369248AFQ39048607-D2B50091-EF62-44F4-B109-5E0CFEA19DFCQ45912821-1F93FC56-6110-4137-A800-0E1E767DB6AAQ47793598-DF869FCA-4194-4803-A7B6-79D8A3B93049Q52656684-8C0F5387-F1DC-4E49-8E38-0679B6D65C99Q58803511-233FAA86-D49C-4BCF-84C7-A246C4ADC331
P2860
Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy of second generation ...... of placebo-controlled trials.
@ast
Efficacy of second generation ...... of placebo-controlled trials.
@en
Efficacy of second generation ...... of placebo-controlled trials.
@nl
type
label
Efficacy of second generation ...... of placebo-controlled trials.
@ast
Efficacy of second generation ...... of placebo-controlled trials.
@en
Efficacy of second generation ...... of placebo-controlled trials.
@nl
prefLabel
Efficacy of second generation ...... of placebo-controlled trials.
@ast
Efficacy of second generation ...... of placebo-controlled trials.
@en
Efficacy of second generation ...... of placebo-controlled trials.
@nl
P2093
P1476
Efficacy of second generation ...... of placebo-controlled trials.
@en
P2093
Kesavan Muralidharan
Konstantinos N Fountoulakis
Lakshmi N Yatham
Leonardo E Silveira
P304
P356
10.1016/J.JAD.2013.04.032
P577
2013-06-02T00:00:00Z